Estrogen receptor (ER) (ER)

The estrogen receptor (ER) is a member of the nuclear hormone receptor superfamily that functions as a ligand-inducible transcription factor (UniProt, Wikipedia). It exists in two primary isoforms, ER-alpha (ESR1) and ER-beta (ESR2), which mediate the biological effects of 17β-estradiol and other estrogens through both genomic and non-genomic signaling pathways (Indigo Biosciences, UniProt). Upon activation by ligand binding, the receptor dimerizes and translocates to the nucleus to bind estrogen response elements (EREs) on DNA, thereby regulating genes essential for growth, reproductive development, and bone homeostasis (Wikipedia, NIH). In clinical medicine, the ER is a hallmark therapeutic target, particularly in breast cancer, where approximately 70% of cases are ER-positive and depend on receptor signaling for tumor progression (PubMed, NIH). Pharmacological management involves selective estrogen receptor modulators (SERMs) that provide tissue-specific agonist or antagonist activity, and selective estrogen receptor degraders (SERDs) that promote the degradation of the receptor protein (PubMed, PMC). Although serum estrogen level is a critical clinical biomarker for evaluating hormonal status and treatment response, the receptor itself is the molecular entity targeted by endocrine therapies (ResearchGate, PubMed).

Other names

ESR1ESR2ER-alphaER-betaEstradiol receptorNuclear receptor subfamily 3 group A member 1Nuclear receptor subfamily 3 group A member 2NR3A1NR3A2

Drugs targeting the estrogen receptor function as agonists, antagonists, selective estrogen receptor modulators (SERMs), or selective estrogen receptor degraders (SERDs) (PMC, PubMed). Agonists mimic natural hormones to activate gene transcription, while antagonists and SERMs compete for the ligand-binding domain to modulate co-regulator recruitment in a tissue-specific manner (Indigo Biosciences, PubMed). SERDs bind and induce structural instability in the receptor, targeting it for ubiquitin-proteasome degradation to eliminate receptor-mediated signaling entirely (PubMed, PMC).